These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29732571)

  • 1. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.
    Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
    Transfusion; 2018 Sep; 58(9):2202-2207. PubMed ID: 29732571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.
    Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
    Vox Sang; 2020 Apr; 115(3):146-151. PubMed ID: 31930543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Watterson D; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Faddy HM
    Transfusion; 2017 Nov; 57(11):2677-2682. PubMed ID: 28718518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.
    Faddy HM; Fryk JJ; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
    Transfusion; 2019 Jul; 59(7):2223-2227. PubMed ID: 31050821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment.
    Keil SD; Bowen R; Marschner S
    Transfusion; 2016 Dec; 56(12):2948-2952. PubMed ID: 27805261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.
    Hobson-Peters J; Amarilla AA; Rustanti L; Marks DC; Roulis E; Khromykh AA; Modhiran N; Watterson D; Reichenberg S; Tolksdorf F; Sumian C; Seltsam A; Gravemann U; Faddy HM
    Transfusion; 2023 Feb; 63(2):288-293. PubMed ID: 36573801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light.
    Rustanti L; Hobson-Peters J; Colmant AMG; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC; Faddy HM
    Transfusion; 2020 Nov; 60(11):2655-2660. PubMed ID: 32830340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates.
    Hashem AM; Hassan AM; Tolah AM; Alsaadi MA; Abunada Q; Damanhouri GA; El-Kafrawy SA; Picard-Maureau M; Azhar EI; Hindawi SI
    Transfus Med; 2019 Dec; 29(6):434-441. PubMed ID: 31696565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light.
    Hindawi SI; Hashem AM; Damanhouri GA; El-Kafrawy SA; Tolah AM; Hassan AM; Azhar EI
    Transfusion; 2018 Jan; 58(1):52-59. PubMed ID: 29239484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro.
    Cap AP; Pidcoke HF; Keil SD; Staples HM; Anantpadma M; Carrion R; Davey RA; Frazer-Abel A; Taylor AL; Gonzales R; Patterson JL; Goodrich RP
    Transfusion; 2016 Mar; 56 Suppl 1(Suppl 1):S6-15. PubMed ID: 27001363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Prow NA; Watterson D; Hall RA; Young PR; Reichenberg S; Sumian C; Faddy HM
    Transfusion; 2016 Sep; 56(9):2278-85. PubMed ID: 27456861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light.
    Praditya D; Friesland M; Gravemann U; Handke W; Todt D; Behrendt P; Müller TH; Steinmann E; Seltsam A
    Vox Sang; 2020 Oct; 115(7):555-561. PubMed ID: 32383163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. West Nile and Usutu viruses are efficiently inactivated in platelet concentrates by UVC light using the THERAFLEX UV-Platelets system.
    Gravemann U; Boelke M; Könenkamp L; Söder L; Maurer M; Ziegler U; Schulze TJ; Seltsam A; Becker SC; Steffen I
    Vox Sang; 2024 Aug; 119(8):827-833. PubMed ID: 38699884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.
    Faddy HM; Fryk JJ; Prow NA; Watterson D; Young PR; Hall RA; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
    Transfusion; 2016 Jun; 56(6 Pt 2):1548-55. PubMed ID: 26926832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis E virus is effectively inactivated by methylene blue plus light treatment.
    Gravemann U; Engelmann M; Kinast V; Burkard T; Behrendt P; Schulze TJ; Todt D; Steinmann E
    Transfusion; 2022 Nov; 62(11):2200-2204. PubMed ID: 36125237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenge study of the pathogen reduction capacity of the THERAFLEX MB-Plasma technology.
    Reichenberg S; Gravemann U; Sumian C; Seltsam A
    Vox Sang; 2015 Aug; 109(2):129-37. PubMed ID: 25899343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraviolet C light efficiently inactivates nonenveloped hepatitis A virus and feline calicivirus in platelet concentrates.
    Gravemann U; Handke W; Lambrecht B; Schmidt JP; Müller TH; Seltsam A
    Transfusion; 2018 Nov; 58(11):2669-2674. PubMed ID: 30267410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a non-denaturing detergent and a guanidinium-based inactivation agent on the viability of Ebola virus in mock clinical serum samples.
    Burton JE; Easterbrook L; Pitman J; Anderson D; Roddy S; Bailey D; Vipond R; Bruce CB; Roberts AD
    J Virol Methods; 2017 Dec; 250():34-40. PubMed ID: 28941617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products.
    Darnell ME; Taylor DR
    Transfusion; 2006 Oct; 46(10):1770-7. PubMed ID: 17002634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.